J. D. Jenks, S. L. Reed, D. Seidel, P. Koehler, O. A. Cornely et al., Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, Int. J. Antimicrob. Agents, vol.52, pp.706-712, 2018.

C. Garcia-vidal, M. Peghin, C. Cervera, C. Gudiol, I. Ruiz-camps et al., Causes of death in a contemporary cohort of patients with invasive aspergillosis, PLoS ONE, vol.10, 2015.

M. Hoenigl, J. P. Gangneux, E. Segal, A. Alanio, A. Chakrabarti et al., Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together, Mycoses, vol.61, pp.885-894, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863269

O. A. Cornely, C. Lass-florl, K. Lagrou, V. Arsic-arsenijevic, and M. Hoenigl, Improving outcome of fungal diseases-Guiding experts and patients towards excellence, Mycoses, vol.60, pp.420-425, 2017.

C. E. Fisher, A. M. Stevens, W. Leisenring, S. A. Pergam, M. Boeckh et al., The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients with Invasive Aspergillosis, Clinical Infectious Diseases, vol.57, pp.1001-1004, 2013.

J. D. Jenks, S. R. Mehta, R. Taplitz, N. Law, S. L. Reed et al., Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies, J. Infect, vol.78, pp.249-259, 2019.

J. D. Jenks, B. Spiess, D. Buchheidt, and M. Hoenigl, New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples, Curr. Fungal. Infect. Rep, vol.13, pp.129-136, 2019.

A. Schauwvlieghe, N. De-jonge, K. Van-dijk, P. E. Verweij, R. J. Bruggemann et al., The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol, Mycoses, vol.61, pp.656-664, 2018.

S. Heldt, J. Prattes, S. Eigl, B. Spiess, H. Flick et al., Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples, J. Infect, vol.77, pp.235-241, 2018.

J. A. Maertens, I. I. Raad, K. A. Marr, T. F. Patterson, D. P. Kontoyiannis et al., Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial, Lancet, vol.387, pp.760-769, 2016.

M. Hoenigl, J. Prattes, B. Spiess, J. Wagner, F. Prueller et al., Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis, J. Clin. Microbiol, vol.52, pp.2039-2045, 2014.

O. A. Cornely, A. Alastruey-izquierdo, D. Arenz, S. C. Chen, E. Dannaoui et al., Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium, Lancet Infect. Dis, vol.12, pp.405-421, 2019.

D. Buchheidt, M. Reinwald, M. Hoenigl, W. K. Hofmann, B. Spiess et al., The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: Strengths and weaknesses, Curr. Opin. Infect. Dis, vol.30, pp.539-544, 2017.

J. D. Jenks, S. R. Mehta, R. Taplitz, S. Aslam, S. L. Reed et al., Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage, Mycoses, vol.62, pp.230-236, 2019.

M. Hoenigl, T. Orasch, K. Faserl, J. Prattes, J. Loeffler et al., Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis, J. Infect, vol.78, pp.150-157, 2019.

M. Hoenigl, S. Eigl, S. Heldt, W. Duettmann, C. Thornton et al., Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis, Mycoses, vol.61, pp.40-43, 2018.

M. Hoenigl, J. Prattes, P. Neumeister, A. Wolfler, and R. Krause, Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study, Mycoses, vol.61, pp.201-205, 2018.

S. Eigl, J. Prattes, M. Reinwald, C. R. Thornton, F. Reischies et al., Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test, Int. J. Antimicrob. Agents, vol.46, pp.401-405, 2015.

S. Eigl, M. Hoenigl, B. Spiess, S. Heldt, J. Prattes et al., Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis, vol.55, pp.528-534, 2017.

J. Springer, M. Lackner, D. Nachbaur, M. Girschikofsky, B. Risslegger et al., Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis, Clin. Microbiol. Infect, vol.22, pp.80-86, 2016.

M. Reinwald, M. Hummel, E. Kovalevskaya, B. Spiess, W. J. Heinz et al., Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies, J. Antimicrob. Chemother, vol.67, pp.2260-2267, 2012.

M. Hoenigl, K. Seeber, C. Koidl, W. Buzina, A. Wolfler et al., Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy, Mycoses, vol.56, pp.471-476, 2013.

H. Guegan, F. Robert-gangneux, C. Camus, S. Belaz, T. Marchand et al., Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays, J. Infect, vol.76, pp.196-205, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01730387

A. Bergeron, R. Porcher, A. Sulahian, C. De-bazelaire, K. Chagnon et al., The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, pp.1831-1837, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00818508

J. F. Camargo and S. Husain, Immune correlates of protection in human invasive aspergillosis, Clin. Infect. Dis, vol.59, pp.569-577, 2014.

C. Garcia-vidal, D. Viasus, and J. Carratala, Pathogenesis of invasive fungal infections, Curr. Opin. Infect. Dis, vol.26, pp.270-276, 2013.

R. Thakur, R. Anand, S. Tiwari, A. P. Singh, B. N. Tiwary et al., Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?, Front. Microbiol, vol.6, p.429, 2015.

S. Heldt, S. Eigl, J. Prattes, H. Flick, J. Rabensteiner et al., Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis, vol.60, pp.818-825, 2017.

R. M. Winn, C. Gil-lamaignere, E. Roilides, M. Simitsopoulou, C. A. Lyman et al., Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species, J. Infect. Dis, vol.188, pp.585-590, 2003.

T. Mercier, E. Guldentops, K. Lagrou, J. Maertens, and . Galactomannan, Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of, Age. Front. Microbiol, vol.9, p.661, 2018.

S. A. Nouer, M. Nucci, N. S. Kumar, M. Grazziutti, B. Barlogie et al., Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: Proposal for a new definition, Clin. Infect. Dis, vol.53, pp.671-676, 2011.

M. Nucci, K. A. Marr, M. J. Vehreschild, C. A. De-souza, E. Velasco et al., Improvement in the outcome of invasive fusariosis in the last decade, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.20, pp.580-585, 2013.

T. M. Hohl, H. L. Van-epps, A. Rivera, L. A. Morgan, P. L. Chen et al., Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display, PLoS Pathog, 2005.

G. M. Gersuk, D. M. Underhill, L. Zhu, and K. A. Marr, Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states, J. Immunol, vol.176, pp.3717-3724, 2006.

V. Espinosa and A. Rivera, First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis, Front. Microbiol, 2016.

A. Carvalho, C. Cunha, R. G. Iannitti, A. Casagrande, F. Bistoni et al., Host defense pathways against fungi: The basis for vaccines and immunotherapy, Front. Microbiol, vol.3, 2012.

P. Borger, G. H. Koeter, J. A. Timmerman, E. Vellenga, J. F. Tomee et al., Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms, J. Infect. Dis, vol.180, pp.1267-1274, 1999.

S. Bidula, D. W. Sexton, A. Abdolrasouli, A. Shah, A. Reed et al., The serum opsonin L-ficolin is detected in lungs of human transplant recipients following fungal infections and modulates inflammation and killing of Aspergillus fumigatus, J. Infect. Dis, vol.212, pp.234-246, 2015.

M. S. Ghufran, K. Ghosh, and S. R. Kanade, A fucose specific lectin from Aspergillus flavus induced interleukin-8 expression is mediated by mitogen activated protein kinase p38, vol.55, pp.323-333, 2017.

S. M. Goncalves, K. Lagrou, C. S. Rodrigues, C. F. Campos, L. Bernal-martinez et al., Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients

C. Cunha, F. Aversa, L. Romani, and A. Carvalho, Human genetic susceptibility to invasive aspergillosis, PLoS Pathog, vol.9, 2013.

L. Y. Chai, M. G. De-boer, W. J. Van-der-velden, T. S. Plantinga, A. B. Van-spriel et al., The Y238X stop codon polymorphism in the human beta-glucan receptor dectin-1 and susceptibility to invasive aspergillosis, J. Infect. Dis, vol.203, pp.736-743, 2011.

C. Cunha, M. Di-ianni, S. Bozza, G. Giovannini, S. Zagarella et al., Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient-and donor-dependent mechanisms of antifungal immunity, Blood, vol.116, pp.5394-5402, 2010.

J. Sainz, C. B. Lupianez, J. Segura-catena, L. Vazquez, R. Rios et al., Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection, PLoS ONE, vol.7, 2012.

P. Y. Bochud, J. W. Chien, K. A. Marr, W. M. Leisenring, A. Upton et al., Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation, N. Engl. J. Med, vol.359, pp.1766-1777, 2008.

M. G. De-boer, H. Jolink, C. J. Halkes, P. L. Van-der-heiden, D. Kremer et al., Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation, PLoS ONE, vol.6, 2011.

C. Cunha, G. Giovannini, A. Pierini, A. S. Bell, G. Sorci et al., Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients, PLoS ONE, vol.6, 2011.

M. Mezger, M. Steffens, M. Beyer, C. Manger, J. Eberle et al., Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells, Blood, vol.111, pp.534-536, 2008.

M. C. Herrero-sanchez, E. B. Angomas, C. De-ramon, J. J. Telleria, L. A. Corchete et al., Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients, Infect. Immun, vol.86, pp.709-727, 2018.

A. S. Brunel, A. Wojtowicz, F. Lamoth, O. Spertini, D. Neofytos et al., Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy, Haematologica, vol.103, pp.527-530, 2018.

A. Wojtowicz, T. D. Lecompte, S. Bibert, O. Manuel, S. Rueger et al., PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant, Clin. Infect. Dis, vol.61, pp.619-622, 2015.

C. Cunha, F. Aversa, J. F. Lacerda, A. Busca, O. Kurzai et al., Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation, N. Engl. J. Med, vol.370, pp.421-432, 2014.

T. Benet, N. Voirin, M. C. Nicolle, S. Picot, M. Michallet et al., Estimation of the incubation period of invasive aspergillosis by survival models in acute myeloid leukemia patients, Med. Mycol. Off. Publ. Int. Soc. Hum. Anim. Mycol, vol.51, pp.214-218, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00965795

C. Garcia-vidal, C. Royo-cebrecos, M. Peghin, A. Moreno, I. Ruiz-camps et al., Environmental variables associated with an increased risk of invasive aspergillosis, Clin. Microbiol. Infect, vol.20, pp.939-945, 2014.

A. Schauwvlieghe, B. J. Rijnders, N. Philips, R. Verwijs, L. Vanderbeke et al., Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study, Lancet Respir. Med, vol.6, pp.782-792, 2018.

E. Roilides, D. P. Kontoyiannis, and T. J. Walsh, Host defenses against zygomycetes, Clin. Infect. Dis, vol.2012, pp.61-66

S. Wurster, V. Thielen, P. Weis, P. Walther, J. Elias et al., Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins, vol.8, pp.1708-1718, 2017.

A. Warris, M. G. Netea, P. E. Verweij, P. Gaustad, B. J. Kullberg et al., Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi, Med. Mycol, vol.43, pp.613-621, 2005.

R. F. Duarte, I. Sanchez-ortega, I. Cuesta, M. Arnan, B. Patino et al., Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis, Clin. Infect. Dis, vol.59, pp.1696-1702, 2014.

O. A. Cornely, J. Maertens, D. J. Winston, J. Perfect, A. J. Ullmann et al., Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia, N. Engl. J. Med, vol.356, pp.348-359, 2007.

J. D. Jenks, S. R. Mehta, and M. Hoenigl, Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?, Med. Mycol, vol.2019, pp.168-178

O. A. Cornely, M. Hoenigl, C. Lass-florl, S. C. Chen, D. P. Kontoyiannis et al., Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology, Mycoses, vol.62, pp.716-729, 2019.

M. J. Becker, S. De-marie, M. H. Fens, H. A. Verbrugh, and I. A. Bakker-woudenberg, Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis, J. Antimicrob. Chemother, vol.52, pp.428-434, 2003.

L. Chai, M. G. Netea, S. Teerenstra, A. Earnest, A. G. Vonk et al., Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive Aspergillosis, J. Infect. Dis, vol.202, pp.1454-1462, 2010.

S. A. Rawlings, S. Heldt, J. Prattes, S. Eigl, J. D. Jenks et al., Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients with Suspected Pulmonary Mold Infection, Front. Immunol, vol.10, 1798.

A. Steinbach, O. A. Cornely, H. Wisplinghoff, A. C. Schauss, J. J. Vehreschild et al., Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective study, Mycoses, vol.62, pp.562-569, 2019.

P. Bacher, A. Steinbach, O. Kniemeyer, A. Hamprecht, M. Assenmacher et al., Fungus-specific CD4(+) T cells for rapid identification of invasive pulmonary mold infection, Am. J. Respir. Crit. Care. Med, vol.191, pp.348-352, 2015.

Z. Oesterreicher, S. Eberl, and M. Zeitlinger, Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole blood, Infection, 2019.

T. Zelante, A. De-luca, P. Bonifazi, C. Montagnoli, S. Bozza et al., IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance, Eur. J. Immunol, vol.37, pp.2695-2706, 2007.

K. L. Becker, D. C. Ifrim, J. Quintin, M. G. Netea, and F. L. Van-de-veerdonk, Antifungal innate immunity: Recognition and inflammatory networks, Semin. Immunopathol, vol.37, pp.107-116, 2015.

G. Lopez-castejon and D. Brough, Understanding the mechanism of IL-1beta secretion, Cytokine. Growth. Factor. Rev, vol.22, pp.189-195, 2011.

K. Seeber, W. Duettmann, R. Krause, and M. Hoenigl, Usefulness of the serum galactomannan assay for early response assessment and treatment stratifications of invasive aspergillosis, Curr. Fungal Infect. Rep, vol.6, pp.198-205, 2012.

D. Neofytos, R. Railkar, K. M. Mullane, D. N. Fredricks, B. Granwehr et al., Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis, PLoS ONE, vol.10, 2015.

E. Roilides, A. Anastasiou-katsiardani, A. Dimitriadou-georgiadou, I. Kadiltsoglou, S. Tsaparidou et al., Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus, J. Infect. Dis, vol.178, pp.1734-1742, 1998.

L. Potenza, D. Vallerini, P. Barozzi, G. Riva, F. Forghieri et al., Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients, PLoS ONE, vol.8, 2013.